Manuela Rocha Bueno

Dr. Manuela Rocha Bueno

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2020 in Molecular Oral Microbiology
Verified
Journal Article
Closed access
PDF file
KIKARIN HITOMI ISHIKAWA
KARIN HITOMI ISHIKAWA
MBManuela Rocha Bueno
Manuela Rocha Bueno
DKDione Kawamoto
Dione Kawamoto
MSMaria Regina Lorenzetti Simionato
Maria Regina Lorenzetti Simionato
MMMarcia Pinto Alves Mayer
Marcia Pinto Alves Mayer

13 December 2019 in Journal of Periodontology
Verified
Journal Article
Closed access
PDF file
IFIsabela Lima França‐Grohmann
Isabela Lima França‐Grohmann
JSJoão Paulo Menck Sangiorgio
João Paulo Menck Sangiorgio
MBManuela Rocha Bueno
Manuela Rocha Bueno
RCRenato Correa Viana Casarin
Renato Correa Viana Casarin
KRKarina Gonzales Silvério Ruiz
Karina Gonzales Silvério Ruiz
ESEnilson Antonio Sallum
Enilson Antonio Sallum

23 December 2025 in Journal of Oral Microbiology
Verified
Journal Article
Open access
PTPedro Henrique Moreira Paulo Tolentino
Pedro Henrique Moreira Paulo Tolentino
RDRoberto Galvão Dinelli
Roberto Galvão Dinelli
HGHernan Santiago Garzón
Hernan Santiago Garzón
DSDaniel R Suárez
Daniel R Suárez
MCMayra Alexandra Téllez Corral
Mayra Alexandra Téllez Corral
BBBruno Bueno-Silva
Bruno Bueno-Silva
This study evaluated the antimicrobial effect of cannabidiol (CBD) on a multi-species subgingival biofilm model. Biofilms were formed using 33 bacterial species on a Calgary device. Two protocols were tested: (A) biofilm in contact with CBD (125, 250 and 500 µg/mL) and chlorhexidine 0.12% (CHX) for the entire period; (B) treatments with CBD (500 and 1000 µg/mL) and CHX started on day 3, twice a day, for 1 minute. The total biofilm counts, the proportion of complexes, and the counts of each species were evaluated by DNA-DNA hybridization (Checkerboard). In Experiment A, CBD at concentrations of 250 and 500 µg/mL, as well as CHX, significantly reduced the total biofilm count. At 500 µg/mL, CBD also decreased the proportion of the red complex and reduced the counts of 10 bacterial species, whereas CHX affected 20 species. In Protocol B, both CBD at 1000 µg/mL and CHX reduced the total biofilm count and the proportion of the red complex, while increasing the proportion of the green complex. Both protocols led to a reduction in Porphyromonas gingivalis and Tannerella forsythia. CBD reduced the total bacterial count and the red complex, inhibiting known periodontal pathogens. Within the limitations, the results provide exploratory evidence that CBD may reduce the total bacterial count in the proposed polymicrobial biofilm model, including the red complex bacteria, and may thus be postulated as an inhibitor of known periodontal pathogens. However, future in vivo studies with robust sample sizes and standardized CFU-based quantification are required to confirm these findings.

Verified
Journal Article
Open access
PDF file
CRCatarina Medeiros Rocha
Catarina Medeiros Rocha
DKDione Kawamoto
Dione Kawamoto
FMFernando Henrique Martins
Fernando Henrique Martins
MBManuela Rocha Bueno
Manuela Rocha Bueno
KIKARIN HITOMI ISHIKAWA
KARIN HITOMI ISHIKAWA
MMMarcia Pinto Alves Mayer
Marcia Pinto Alves Mayer
Oral bacteria are implicated not only in oral diseases but also in gut dysbiosis and inflammatory conditions throughout the body. The periodontal pathogen Aggregatibacter actinomycetemcomitans (Aa) often occurs in complex oral biofilms with Streptococcus gordonii (Sg), and this interaction might influence the pathogenic potential of this pathogen. This study aims to assess the impact of oral inoculation with Aa, Sg, and their association (Aa+Sg) on alveolar bone loss, oral microbiome, and their potential effects on intestinal health in a murine model. Sg and/or Aa were orally administered to C57Bl/6 mice, three times per week, for 4 weeks. Aa was also injected into the gingiva three times during the initial experimental week. After 30 days, alveolar bone loss, expression of genes related to inflammation and mucosal permeability in the intestine, serum LPS levels, and the composition of oral and intestinal microbiomes were determined. Alveolar bone resorption was detected in Aa, Sg, and Aa+Sg groups, although Aa bone levels did not differ from that of the SHAM-inoculated group. Il-1β expression was upregulated in the Aa group relative to the other infected groups, while Il-6 expression was downregulated in infected groups. Aa or Sg downregulated the expression of tight junction genes Cldn 1, Cldn 2, Ocdn, and Zo-1 whereas infection with Aa+Sg led to their upregulation, except for Cldn 1. Aa was detected in the oral biofilm of the Aa+Sg group but not in the gut. Infections altered oral and gut microbiomes. The oral biofilm of the Aa group showed increased abundance of Gammaproteobacteria, Enterobacterales, and Alloprevotella, while Sg administration enhanced the abundance of Alloprevotella and Rothia. The gut microbiome of infected groups showed reduced abundance of Erysipelotrichaceae. Infection with Aa or Sg disrupts both oral and gut microbiomes, impacting oral and gut homeostasis. While the combination of Aa with Sg promotes Aa survival in the oral cavity, it mitigates the adverse effects of Aa in the gut, suggesting a beneficial role of Sg associations in gut health.

27 May 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
TMTatiane Tiemi Macedo
Tatiane Tiemi Macedo
LMLarissa Matias Malavazi
Larissa Matias Malavazi
GVGustavo Quilles Vargas
Gustavo Quilles Vargas
FGFrancisco Jerfeson dos Santos Gonçalves
Francisco Jerfeson dos Santos Gonçalves
AGAline Paim de Abreu Paulo Gomes
Aline Paim de Abreu Paulo Gomes
BBBruno Bueno-Silva
Bruno Bueno-Silva
The aim of this study was to evaluate the effect of the combination of neovestitol–vestitol (CNV) compounds obtained from Brazilian red propolis on the microbiological profile of a mature multispecies subgingival biofilm. The biofilm with 32 bacterial species associated with periodontitis was formed for seven days using a Calgary device. Treatment with CNV (1600, 800, 400, and 200 μg/mL), amoxicillin (54 μg/mL), and vehicle control was performed for 24 h on the last day of biofilm formation. Biofilm metabolic activity and DNA–DNA hybridization (checkerboard) assays were performed. The groups treated with CNV 1600 and amoxicillin reduced 25 and 13 species, respectively, compared to the control vehicle treatment (p ≤ 0.05); both reduced P. gingivalis, while only CNV reduced T. forsythia. When the data from the two treatments (CNV and AMOXI) were compared, a statistically significant difference was observed in 13 species, particularly members of Socransky’s orange complex. Our results showed that CNV at 1600 μg/mL showed the best results regarding the metabolic activity of mature biofilms and obtained a reduction in species associated with the disease, such as T. forsythia, showing a better reduction than amoxicillin. Therefore, CNV seems to be a promising alternative to eradicate biofilms and reduce their pathogenicity.

22 April 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
MBManuela Rocha Bueno
Manuela Rocha Bueno
FMFernando Henrique Martins
Fernando Henrique Martins
CRCatarina M. Rocha
Catarina M. Rocha
DKDione Kawamoto
Dione Kawamoto
KIKARIN HITOMI ISHIKAWA
KARIN HITOMI ISHIKAWA
MMMarcia Pinto Alves Mayer
Marcia Pinto Alves Mayer
The benefits of probiotics on dysbiotic microbiomes and inflammation are dependent on the tested strain, host factors, and the resident microbiome. There is limited knowledge on the effects of probiotics in A. actinomycetemcomitans-associated periodontitis. Thus, Lactobacillus acidophilus LA5 (LA5) was orally inoculated for 30 days in C57Bl/6 mice infected with A. actinomycetemcomitans JP2 (Aa) and S. gordonii (Sg). Alveolar bone loss, gingival gene expression, and oral and gut microbiomes were determined. LA5 controlled bone loss in Aa+Sg-infected mice, downregulated the expression of Il-1β and upregulated Il-10 in gingival tissues, and altered the oral and gut microbiomes. LA5 increased the diversity of the oral microbiome of Aa+Sg infected mice, and Aa+Sg and Aa+Sg+LA5 oral or gut microbiomes clustered apart. LA5 induced shifts in Aa+Sg infected mice by increasing the abundance of Muribaculaceae and decreasing Bifidobacteriaceae in the oral cavity and increasing the abundance of Verrucomicrobiae and Eggerthellales in the gut. In conclusion, LA5 oral administration controls experimental Aa-associated periodontitis by altering inflammatory gene expression and the oral and gut microbiomes.